Ginkgo biloba (EGb 761) in the treatment of equilibrium disorders
We know when we manage our patients with type 2 diabetes, we not only need to be concerned about glycemic control, but also about reducing cardiometabolic risk as well as weight reduction since most of our patients are overweight or obese, Juan P
This prevents trans-epidermal water loss, giving the skin a dewy, hydrated, and luminous appearance
For those considering Cerebrolysin, key limitations include: no prevention trials have been conducted (all studies in existing disease), optimal dosing remains uncertain (higher doses may actually be less effective), batch-to-batch variability in peptide content, and the inconvenience of repeated IV infusion cycles
We may recommend BPC-157 for clients dealing with: Your specific dose, delivery method, and length of use depend on your health status, lifestyle, and goals